Plant medicine is the oldest form of health care known to mankind. Syzygium guineense is one of the many species of Ethiopian medicinal plants which has a long history of use as remedies for various ailments such as dysentery, diarrhea, and hypertension. In many countries, herbal medicines and related products are introduced into the market without safety or toxicological evaluation. The aim of this study was to investigate the histopathological effect of 80% methanol extract of S. guineense on liver and kidney and blood parameters of rats. For acute toxicity study, rats were randomly divided into three groups (n=4). The control group received distilled water, while the experimental groups received a single dose of 2000 mg/kg and 5000 mg/kg 80% methanolic extract of S. guineense leaves per oral. For subacute toxicity study, the rats were randomly divided into three groups (n=6). The control group received distilled water, while the experimental groups received 500 mg/kg and 1500 mg/kg 80% methanol extract of S. guineense leaves orally for 28 days. At the end of the experiment, blood samples were collected for hematology and clinical chemistry evaluations. Gross pathology and histopathology of liver and kidneys were assessed. In the acute toxicity study, rats treated with 2000 mg/kg and 5000 mg/kg showed no toxicological signs observed on behavior, gross pathology, and body weight of rats. In the subacute toxicity study rats have showed no significant changes on behavior, gross pathology, body weight, and hematological and biochemical parameters, whereas both experimental groups had a lower blood glucose level compared with the control group (p < 0.05). There were no significant differences in the gross and histopathology of the liver and kidneys of experimental animals in extract exposed groups and their counterpart control. The 80% methanol extract of S. guineense does not produce adverse effects in rats after acute and subacute treatment. Before marketing a S. guineense leaf based remedy, subchronic and chronic toxicity evaluations need to be done.

Background: Diseases of the thyroid are manifested by alteration in hormone secretion, enlargement of the thyroid gland (goiter), or both. The principal diseases of the thyroid gland are goiter (diffuse or nodular), hypo or hyperthyroidism, thyroiditis and neoplasms. The incidence and prevalence of these thyroid diseases in a given community are variable depending on various factors. Simple (non-toxic) goiter is extremely common throughout the world and is most prevalent in mountainous areas. The reported prevalance of goiter in Ethiopia varies between 18% and 30%. Objective: To review the histopathologic patterns of thyroid disease and their relationship with age and sex over a five year period. Setting: Tikur Anbessa teaching and referral hospital, Department of Pathology, Faculty of Medicine, Addis Ababa University. Methods: Retrospective analysis of five years biopsy material from patients with thyroid disease. Results: Seven hundred and eighty consecutive patients with thyroid disease were included in the study. Six hundred and sixty(79%) were found to be non-neoplastic and 164 (21%) were neoplastic. Nodular colloid goiter (NCG) were found in 600 (76.9%) cases. Adenoma, carcinoma and thyroiditis accounted for 100 (12.8%), 64 (8.2%) and 16 (2.1%) cases respectively. Female to male ratio was 4.5:1. Eighty five point seven per cent of the thyroid diseases were found in the age group 20-59 years. Conclusion: Nodular colloid goiter is the most prevalent thyroid disease. Papillary carcinoma is the most frequent cancer seen in this series. Appropriate measures should be taken to reduce the iodine deficiency states in the diet to alleviate the social and medical consequences of the NCG. Similary clinical evaluation of goiter should be thorough, and use all means especially histopathologic study of the specimens to arrive at a definitive diagnosis as thyroid carcinoma is not uncommon.

Background: Moringa stenopetala and related species are commonly used in folk medicine for various human diseases such as antimalarial, antihypertensive, antidiabetic and as antispasmodic. Objective: The aim of the study is to evaluate the effects of aqueous extract of M. stenopetala on blood parameters, and histopathology of liver and kidney in experimental mice. Methods: Fresh leaves of M. stenopetala were collected from Arbaminch area, Southwest Ethiopia, in November 2005. The leaves were dried and extracted with water. Three month-old Swiss albino male mice, which were kept under uniform laboratory conditions, were randomly divided into four groups (one group of controls and three experimental). (The control group was orally given 0.5 ml of distilled water, and groups II, III and IV were given the aqueous leaf extract of M. stenopetala using intragastric tube to achieve the required doses of 600, 750 and 900 mg/kg body weight, respectively once a day at 24 hours intervals for six weeks and then sacrificed). Blood sample was collected from each mouse and examined for hematological and biochemical parameters. Liver and kidney were removed, stained and examined for histopathological profiles. The effects of treatment with aqueous extract of M. stenopetala on hematological, biochemical and histopathology features were compared with control group following standard procedures. Results: Mice treated with 900 mg/kg of the extract per kg of body weight showed a significant increase in body weight compared to the controls (P=0.014). Neither a significant change in the weight nor in histopathology of liver and kidney were observed in the animals treated with aqueous extract of M. stenopetala compared to those of the controls. Serum glucose level (P=0.034) and serum cholesterol level (P=0.016) decreased significantly after six weeks treatment. Conclusion:The aqueous leaf extract of M. stenopetala is shown to increase body weight and reduce serum glucose and cholesterol level in mice. This indicates nutritional and medicinal values, but we cannot yet recommend its therapeutic use before more and complete studies are done. [Ethiop J Health Dev. 2011;25(1):51-57]

BackgroundIn southeast Ethiopia, people locally use the roots of Gnidia stenophylla Gilg (Thymelaeaceae) to cure malaria and other diseases with no literature evidence substantiating its safety. The aim of this study was, therefore, to investigate the safety of the aqueous root extract of G. stenophylla after acute (single dose) and repeated sub chronic oral administration in mice.ResultsA single oral administration of the extract at 500, 1000, 2000 and 4000 mg/kg body weight did not induce any behavioral change and mortality in both sexes. The oral LD50 of the extract was found to be above 6000 mg/kg body weight in mice. Chronic treatment with the extract for 13 weeks did not induce any sign of illness and/or death and had no adverse effect on the body weight. Dose-related elevations of erythrocytes, hematocrit, hemoglobin, platelets and neutrophils differential and significant decrease in the number of lymphocyte were observed. Liver sections of mice treated with 800 mg/kg body weight, revealed mild inflammations around the portal triads and central veins; whereas the spleen and kidneys appeared normal with no detectable gross morphological and histopathological alteration at both doses.ConclusionsThe results of this study revealed that aqueous root extract of G. stenophylla Gilg at antimalarial dose is safe even when taken for a longer period. At a higher dose, the extract may have a potential to increase some hematological indices but may induce mild hepatotoxicity as a side effect.Electronic supplementary materialThe online version of this article (10.1186/s13104-017-2964-3) contains supplementary material, which is available to authorized users.

BackgroundCervical cancer is the second most prevalent cancer among women of child-bearing age in Ethiopia. The aim of this study was to determine human papilloma virus (HPV) genotype distribution among HIV-negative women with normal and abnormal cervical cytology results.MethodsWe investigated a consecutive of 233 HIV-negative women between December 2008 and March 2009 presenting in a Tertiary Gynecology Referral Clinic in Ethiopia. Screening was done by Pap cytology and HPV detection and genotyping method was nested PCR (direct amplification with MY09/MY11 primers, followed by nested amplification with GP5/GP6 primers) and sequencing of the nested products. Sequencing of the non-purified nested PCR products was performed following re-amplification with Big dye terminator, using the GP6 primer.ResultsOf the 233 study participants, 92 (39.5%) had abnormal cytology. All women with abnormal cervical cytology had positive HPV DNA compared to only 48.9% of those presenting with normal cytology. Of these women, the frequency of high-risk (HR)-HPV was 83.2% and its prevalence in women with abnormal cervical cytology was significantly higher than those with normal cytology (92.4% vs. 71%, p < 0.0001). The most frequent genotypes identified were HPV16 (44.1%), followed by HPV35 and HPV45 (each 6.2%), HPV31 (4.4%), HPV56 (3.7%), HPV18 and HPV59 (each 3.1%), HPV58 (2.5%) and HPV39 (1.9%). While the most common HR-HPV infections among women with normal cytology were HPV16 (20.3%), followed by HPV35 (8.7%), HPV56 and HPV58 (each 5.8%), HPV18, HPV31 and HPV39 (each 4.4%), HPV45 (2.9%) and HPV59 and HPV68 (each 1.5%), the most common HR-HPV infections in women with abnormal cytology included HPV16 (62%), followed by HPV45 (8.7%), HPV 31, HPV35 and HPV59 (each 4.4%), and HPV18, HPV52 and HPV56 (each 2.2%). We also noted low prevalence of multiple HPV infections in women with normal or abnormal cytology. Multivariable logistic analysis showed that residing in rural area (OR 3.24, 95% CI: 1.13–9.30), being multipara (OR 7.35, 95% CI: 1.78–30.38) and having abnormal cervical cytology results (OR 6.75, 95% CI: 1.78–25.57) were all independently associated with HPV16 genotype.ConclusionsOur study revealed a significant risk of infection with HR-HPV, in particular with HPV16 genotype, in women attending a referral center in Ethiopian women presenting with or without abnormal cervical cytology. Moreover, Pap smear cytology missed a significant proportion of women compared to those who were identified by PCR for HR-HPV infections. In addition, the PCR method we used was not suitable for sensitive detection of co-existent multiple infections. Data from the present study indicate that currently available HPV vaccines could prevent nearly 67% of all cervical cancer cases in women in Ethiopia.Electronic supplementary materialThe online version of this article (10.1186/s13027-018-0201-x) contains supplementary material, which is available to authorized users.